Healthcare startups that function as contract research organizations to validate health tech for payers, health systems and pharmaceutical companies are an emerging trend. But one company that’s providing a different approach in this category is Litmus Health. The company uses data from wearables and other devices to support Phase 1 and Phase 2 clinical trials for pharmaceutical companies and other institutions.
This week, Litmus Health launched its public beta, according to a news release.
The advantage of the company’s approach is that wearables and other connected devices are already in the hands of consumers, said Litmus CEO Daphne Kis in the release.
